Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from AbCellera Biologics (ABCL) is now available.
On May 7, 2024, during its earnings call, the Company will review its first-quarter results, supported by a corporate presentation. The information provided, including any exhibits, is for informational purposes and is not considered legally filed under the Securities Exchange Act, nor is it incorporated into any official filings, unless explicitly stated.
Find detailed analytics on ABCL stock on TipRanks’ Stock Analysis page.